Admissions and credentials

New York

Experience

Leads Biolabs Announces HK$1.29 Billion IPO

July 25, 2025

Cooley advised Nanjing Leads Biolabs Co. (Leads Biolabs), a clinical-stage biotechnology company that discovers, develops and commercializes new therapies in oncology, autoimmune and other severe diseases, on its HK$1.29 billion initial public offering (IPO).

Read more

Related contacts

Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Kaiting Yang
Counsel, Hong Kong
Yiying Wang
Counsel, Shanghai
Yunxiang Xu
Associate, Shanghai
Brian Lau
Associate, Hong Kong
Alex Wu
Associate, Shanghai
Daniel Zheng
Associate, Shanghai
Zhengyang Li
International Legal Project Manager, Hong Kong
Cindy Pan
International Legal Project Manager, Hong Kong
Zoe Wang
International Legal Project Manager, Shanghai
Xander Lee
Partner, Santa Monica
Francis Wheeler
Senior Counsel, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Vince Sampson
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC

Related Practices & Industries